Research ArticleOMERACT 2018: International Consensus Conference on Outcome Measures in Rheumatology, Terrigal, Australia, May 2018 Special Interest Groups, Part 1
Patient Perspectives on DMARD Safety Concerns in Rheumatology Trials: Results from Inflammatory Arthritis Patient Focus Groups and OMERACT Attendees Discussion
Kathleen M. Andersen, Ayano Kelly, Anne Lyddiatt, Clifton O. Bingham III, Vivian P. Bykerk, Adena Batterman, Joan Westreich, Michelle K. Jones, Marita Cross, Peter M. Brooks, Lyn March, Beverley Shea, Peter Tugwell, Lee S. Simon, Robin Christensen and Susan J. Bartlett
The Journal of Rheumatology September 2019, 46 (9) 1168-1172; DOI: https://doi.org/10.3899/jrheum.181185
Kathleen M. Andersen
From the Department of Family Medicine, and the Department of Medicine, McGill University, Montreal, Quebec; Ottawa Hospital Research Institute, Ottawa Hospital; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario,
Canada; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen; Department of Rheumatology, Odense University Hospital, Odense,
Denmark; Canberra Rheumatology; College of Health and Medicine, Australian National University, Canberra; Centre for Kidney Research, The Children’s Hospital at Westmead; Institute of Bone and Joint Research-Kolling Institute, University of Sydney; Sydney Medical School, University of Sydney, Sydney; Department of Rheumatology, Royal North Shore Hospital; Institute of Bone and Joint Research, Kolling Institute, Northern Sydney Local Health District, St Leonards; Centre for Health Policy, School of Population and Global Health, The University of Melbourne, Melbourne; Northern Health, Epping,
Australia; Division of Rheumatology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery; Department of Social Work Programs, Hospital for Special Surgery, New York, New York; SDG LLC, Cambridge, Massachusetts,
USA.
Ayano Kelly
Anne Lyddiatt
Clifton O. Bingham III
Vivian P. Bykerk
Adena Batterman
Joan Westreich
Michelle K. Jones
Marita Cross
Peter M. Brooks
Lyn March
Beverley Shea
Peter Tugwell
Lee S. Simon
Robin Christensen
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 46, Issue 9
1 Sep 2019
Patient Perspectives on DMARD Safety Concerns in Rheumatology Trials: Results from Inflammatory Arthritis Patient Focus Groups and OMERACT Attendees Discussion
Kathleen M. Andersen, Ayano Kelly, Anne Lyddiatt, Clifton O. Bingham, Vivian P. Bykerk, Adena Batterman, Joan Westreich, Michelle K. Jones, Marita Cross, Peter M. Brooks, Lyn March, Beverley Shea, Peter Tugwell, Lee S. Simon, Robin Christensen, Susan J. Bartlett
The Journal of Rheumatology Sep 2019, 46 (9) 1168-1172; DOI: 10.3899/jrheum.181185
Patient Perspectives on DMARD Safety Concerns in Rheumatology Trials: Results from Inflammatory Arthritis Patient Focus Groups and OMERACT Attendees Discussion
Kathleen M. Andersen, Ayano Kelly, Anne Lyddiatt, Clifton O. Bingham, Vivian P. Bykerk, Adena Batterman, Joan Westreich, Michelle K. Jones, Marita Cross, Peter M. Brooks, Lyn March, Beverley Shea, Peter Tugwell, Lee S. Simon, Robin Christensen, Susan J. Bartlett
The Journal of Rheumatology Sep 2019, 46 (9) 1168-1172; DOI: 10.3899/jrheum.181185